COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03776500
Recruitment Status : Recruiting
First Posted : December 14, 2018
Last Update Posted : February 27, 2019
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
Innovative Medicines for Tuberculosis

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : October 2019